Loading in 2 Seconds...
Loading in 2 Seconds...
Lunch 11.45 – 13.00 13.00-13.25 Siveke J. Molecular mechanism of tumor development in a mouse model of pancreatic cancer 13.25-13.50 Bruns C Angiogenesis and metastasis regulating genes in pancreatic cancer 13.50-14.15 Lechel A.
Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.
13.00-13.25 Siveke J.
Molecular mechanism of tumor development in a mouse model of pancreatic cancer
13.25-13.50 Bruns C
Angiogenesis and metastasis regulating genes in
13.50-14.15 Lechel A.
Telomerase deletion limits progression of p53-mutant hepatocellular carcinoma with short telomeres in chronic liver disease
14.15-14.40 Müller-Schilling M.
Molecular mechanisms of p53/p63 and p73 in
14.40-15.05 Malek N.P.
Control of cell cycle progression and tissue
homeostasis by p27 and cyclin E
Am Eibsee 1-3D-82491 GrainauPhone: +49-(0)8821-98810
Distance:Grainau: 3 kmGarmisch-Partenkirchen: 11 km München: 97 kmInnsbruck: 68 kmFüssen: 59 km
Molecular pathogenesis and experimental therapy of gastrointestinal cancer –
07.March - 09. March 2007
Medizinische Hochschule Hannover
Carl-Neuberg Straße 1
Telefon: 0511-532 6760
Achtung! Farbwechsel des Vordrucks beachten! An diese Stelle keinen Text stellen!
Division of Molecular Biology, The Netherlands Cancer Institute:
15.05-15.45 Jos Jonkers
Molecular pathways of genomic instability in
Coffee break 15.45-16.15
Immunology and Virotherapy
16.15-16.40 Zender L.
Impact of senescence on innate immunity in a HCC mouse model
16.40-17.05 Greten T.
Role of Tregs and tumor cell death in immunotherapy of HCC
17.05-17.30 Gütgemann I.
A new model for antigen recognition in hepatocellular carcinoma: LAPtTA x c- MYC/OVA transgenic mice
17.30-17.55 Becker P.
Strategies for immune-intervention
17.55-18.20 Ebert O.
Treatment of hepatocellular carcinoma with tumor specific replicating visicular stomatitis virus
18.20-18.45 Kubicka S.
Migration and expansion of dendritic cells as a tool for enhanced crosspresentation of tumorantigens by tumorspecific replicating viruses (Viro- Immunotherapy)
19.30-20.00 Walk with torchlight
20.00 Rustic buffet in the Eibsee cottage
Friday 9th March
State of the art lecture: Academic drug development
Medical School Hannover and HZI:
8.00-8.15 Malek N.P.
Academic drug development for targeted therapy of cancer – part I
8.15-8.30 Kalesse M.
Academic drug development for targeted therapy of cancer – part II
8.30-8.45 Frank R.
Academic drug development for targeted therapy of cancer – part III
New experimental therapies:
8.45-9.10 Mier W.
Endoradiotherapeutic procedures as a tool for tumor therapy
9.10-9.35 Ganten T.
The promise of Trail – potential and risks of novel anti cancer therapy
9.35-10.00 de Toni E.
Sensitising of cancer cells for receptor-mediated
apoptosis: new therapeutic approach for HCC
Coffee break 10.00-10.30
10.30-10.55 Breuhahn, K.
Dysregulation of FUSE-binding transcription
factors in hepatocarcinogenesis
10.55-11.20 Zender L.
New mir30RNA libraries and comparative
oncogenomics in GI oncology
11.20-11.45 Schneider G.
Cell cycle regulation in Pancreatic cancer cells
Thursday 8th March
Cell biology and metabolism
Breakfast 7.30 – 8.00
8.00-8.25 Straub B.
A new form of cell contact: cis-E:N-Cadherin hybrids in normal and malignant liver cells
8.25-8.50 Skawran B.
Chromatin remodeling and induction of chromosomal instability
8.50-9.15 Kern M.
Prostaglandin metabolism in hepatocarcinogenesis
9.15-9.40 Nies A.
Localisation and function of transmembrane transporters in HCC
9.40-10.05 Ryschich E.
Time laps microscopy for investigation of tumor cell migration
10.05-10.30 Urban S.
HepaRG-cells as a tool to study HBV-infection as well as hepatocyte-specific differentiation and polarization processes
10.30-11.00 Bartenschlager R.
Strategies of hepatitis C virus replication and persistence
11.00-11.25 Radlwimmer B.
Array-CGH and gene methylation in HCC
11.25-11.50 Geffers R.
Role of SNPs in carcinogenesis and cancer
13.50-14.15 Gallmeier E
DNA-repair gene alterations as a pharmacogenomic target for the treatment of
14.15-14.40 Kolligs F
Critical genes for development of colorectal
cancer: new therapeutic targets?
14.40-15.05 Singer S.
Mikrotubuli destabilising proteins as therapeutic targets for hepatocellular carcinoma
Lunch 11.50 – 13.50
Potential therapeutic targets